Entry decisions in the generic pharmaceutical industry

RAND Journal of Economics

Volumn 30, Issue 3, 1999, Pages 421-440

  Scott Morton, Fiona M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; COST; DRUG APPROVAL; DRUG INDUSTRY; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; UNITED STATES;

COSTS AND COST ANALYSIS; DRUG APPROVAL; DRUG INDUSTRY; DRUGS, GENERIC; EFFICIENCY, ORGANIZATIONAL; HUMANS; MARKETING OF HEALTH SERVICES; MODELS, ORGANIZATIONAL; ORGANIZATIONAL OBJECTIVES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0033195434     PISSN: 07416261     EISSN: None     Source Type: Journal    
DOI: 10.2307/2556056     Document Type: Article

References (13)

1. BERRY, S.T. "Estimation of a Model of Entry in the Airline Industry." Econometrica, Vol. 60 (1992), pp. 889-917.
2. BOLTON, P. AND FARRELL, J. "Decentralization, Duplication, and Delay." Journal of Political Economy, Vol. 98 (1990), pp. 803-826.
3. BRESNAHAN, T.F. AND REISS, P.C. "Do Entry Conditions Vary Across Markets?" Brookings Papers in Economic Activity (1987), pp. 833-871.
4. _ AND _. "Empirical Models of Discrete Games." Journal of Econometrics, Vol. 48 (1991), pp. 57-81.
5. CAVES, R.E., WHINSTON, M.D., AND HURWITZ, M.A. "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry." Brookings Papers on Economic Activity (1991), pp. 1-48.
6. CHRISTENSEN, L.R. AND CAVES, R.E. "Cheap Talk and Investment Rivalry in the Pulp and Paper Industry." Journal of Industrial Economics, Vol. 45 (1997), pp. 47-73.
7. DIXIT, A. AND SHAPIRO, C. "Entry Dynamics with Mixed Strategies." In L.G. Thomas, ed., The Economics of Strategic Planning. Lexington, Mass: Lexington Books, 1986.
8. FRANK, R.G. AND SALKEVER, D.S. "Generic Entry and the Pricing of Pharmaceuticals." Journal of Economics and Management Strategy, Vol. 6 (1997), pp. 75-90.
9. KELLER, K.L. Strategic Brand Management: Building, Measuring, and Managing Brand Equity. Upper Saddle River, N.J.: Prentice-Hall, 1998.
10. ROTEMBERG, J.J. AND SALONER, G. "Benefits of Narrow Business Strategies." American Economic Review, Vol. 84 (1994), pp. 1330-1149.
11. SCOTT MORTON, F. "Brand Advertising, Barriers to Entry, and Generic Entry in the U.S. Pharmaceutical Market." International Journal of Industrial Organization, forthcoming.
12. SHERMAN, R. AND WILLETT, T. "Potential Entrants Discourage Entry." Journal of Political Economy, Vol. 75 (1967), pp. 400-403.
13. WIGGENS, S. AND MANESS, R. "Price Competition in Pharmaceuticals: The Case of Antiinfectives." Mimeo, Texas A&M, 1995.